What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s customer receivables and other?

Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s customer receivables and other has grown at a 65.3% compound annual growth rate (CAGR), from $3.49M to $15.75M.

Tarsus Pharmaceuticals, Inc. TARS Customer receivables and Other

Customer receivables and Other at other companies

Morgan StanleyMS

$2.52B+0.4%

Raymond James FinancialRJF

$1.81B-3.5%

Chicago Atlantic Real Estate FinanceREFI

$2.56M+388%

Customers BancorpCUBI

$2.37M+25.7%

Arbor Realty TrustABR

$35.25M+267%

Ares Management CorporationARES

$0-100%

Segments

By segment

See full

Reportable Segment$3.72M+7.8%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s customer receivables and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s customer receivables and other?: Tarsus Pharmaceuticals, Inc. (TARS) reported customer receivables and other of $3.72M in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s customer receivables and other changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s customer receivables and other increased by 7.8% year-over-year, from $3.45M to $3.72M.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s customer receivables and other?: Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s customer receivables and other has grown at a 65.3% compound annual growth rate (CAGR), from $3.49M to $15.75M.